Investigators sought to determine whether adjuvant pembrolizumab is associated with the risk of developing subsequent cutaneous malignant neoplasms in patients with high-risk stage II melanoma.
Whole-pelvis RT linked to improved PFS for patients with prostate cancer staged TrN0M0, while ADT linked to improved PFS in patients staged N1/M1 ...
In AYAs, the ASH guideline panel recommends pediatric-inspired (asparaginase-containing) regimens for treatment-naïve B-ALL and T-ALL, and blinatumomab for relapsed/refractory B-ALL.
Study researchers surveyed community-based physicians in order to understand what drives treatment decision-making in mCRC in the third-line setting.
In this analysis, researchers aimed to determine whether intermediate dose escalation is beneficial in resectable, stage III NSCLC patients who receive definitive concurrent chemoradiation followed by ...
On the same day the lawsuit was filed, the administration also announced plans to cut another $183 million in unused public health funds. That round of cuts includes block grants from the U.S. Centers ...
The NDA is supported by data from part A of the phase 2 PROSPECT trial, which evaluated tirabrutinib in 48 adult patients with R/R PCNSL.
The NDA is supported by data from the EXCALIBER-RRMM trial, which evaluated the safety and efficacy of iberdomide, an investigational cereblon E3 ligase modulator.
Lori Kelley crochets at home in Harrisburg, North Carolina. With deteriorating eyesight, she relies mainly on her sense of touch while creating projects. (A.M. Stewart for KFF Health News) Medicaid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results